TipRanks on MSN

MBX Biosciences Announces Public Offering Agreement

An update from MBX Biosciences, Inc. ( ($MBX) ) is now available. On September 24, 2025, MBX Biosciences, Inc. entered into an Underwriting ...

Stitch Fix Posts Q4 Results, Joins Transocean, MBX Biosciences And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

U.S. stock futures were mixed this morning, with the Dow futures gaining around 0.1% on Thursday. Shares of Stitch Fix, Inc. ...

Evaxion Licenses EVX-B3 Vaccine Candidate to Merck

Evaxion has licensed its EVX-B3 vaccine candidate to Merck & Co. in a deal potentially worth more than $600 million to the clinical-stage biotechnology company.

MBX Biosciences, Inc. (MBX) Discusses On Topline Results From Avail Phase 2 Trial Transcript

Ladies and gentlemen, greetings, and welcome to MBX Biosciences Conference Call. Today's call is being recorded. [Operator Instructions] As a reminder, this conference is being recorded. It is now my ...
TipRanks on MSN

MBX Biosciences price target raised to $80 from $38 at Oppenheimer

Oppenheimer raised the firm’s price target on MBX Biosciences (MBX) to $80 from $38 and keeps an Outperform rating on the shares after the company ...